Akebia Therapeutics Inc (NASDAQ:AKBA)

3.36
Delayed Data
As of Nov 15
 +0.14 / +4.35%
Today’s Change
2.99
Today|||52-Week Range
10.45
-39.24%
Year-to-Date

Today’s Trading

Previous close3.22
Today’s open3.26
Day’s range3.23 - 3.43
Volume1,707,750
Average volume (3 months)841,531
Market cap$400.8M
Data as of 3:59pm ET, 11/15/2019

Growth & Valuation

Earnings growth (last year)-39.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)+16.72%
P/E ratioNM
Price/Sales1.54
Price/Book0.62

Competitors

 Today’s
change
Today’s
% change
BSTCBiospecifics Technol...+0.06+0.11%
REPHRecro Pharma Inc+0.59+3.57%
ARDXArdelyx Inc-0.01-0.16%
KRTXKaruna Therapeutics ...+0.29+1.67%
Data as of 4:00pm ET, 11/15/2019

Financials

Next reporting dateMarch 4, 2020
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$207.7M
Annual profit (last year)-$143.6M
Net profit margin-69.12%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts